Pharmacy and Pharmaceutical Sciences > News > Faculty & Student Scholarship > October 2024 Updates

October 2024 Updates

The Faculty and Student Scholarship section is provided as a service to the WSU College of Pharmacy and Pharmaceutical Sciences community for sharing publications, presentations, and other highly transactional types of information. Accuracy of the information presented is the responsibility of those who submitted it. Submissions are reviewed for compliance with state statutes and ethics guidelines but are not edited for spelling, grammar, or clarity. Submission for Pharmaceutical Sciences faculty and PhD students can be directed to Kami Ryplewski and submissions for Pharmacotherapy faculty and Doctor of Pharmacy students to Faith Townsend.

Faculty Scholarship

Publications

  • Staten AR, Baker DE. Cefepime/enmetazobactam. Hospital Pharmacy. 2024; ePub ahead of print. August 12, 2024. doi.org/10.1177/00185787241269112
  • Levien TL, Baker DE. Drug Evaluation – Tislelizumab (Tevimbra).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  August 2024.
  • Hitt EM, Baker DE. Drug Evaluation – Givinostat (Duvyzat).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  August 2024.
  • Baker DE. Drug Evaluation – Atidarsagene autotemcel (Lenmeldy).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  August 2024.
  • Hitt EM, Baker DE. Drug Evaluation – Danicopan (Voydeya).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  August 2024.
  • Levien TL, Baker DE. Drug Evaluation – Lifileucel (Amtagvi).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  August 2024.
  • Baker DE. Drug Utilization Evaluation – Iloprost (Aurlumyn).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Clinical Drug Information, LLC.  August 2024.
  • Baker DE. Drug Evaluation – Fidanacogene elaparvovec-dzkt.  In: Forrence E, Baker DE (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  September 2024.
  • Baker DE. Drug Evaluation – Nogapendekin alfa inbakicept-pmln (Anktiva).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  September 2024
  • Baker DE. Drug Evaluation – Nogapendekin alfa inbakicept-pmln (Anktiva). In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  September 2024.
  • Levien TL, Baker DE. Drug Evaluation – Pemivibart (Pemgarda): Preliminary Evaluation.  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  September 2024.
  • Baker DE. Drug Utilization Evaluation – Pivmecillinam (Pivya).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Clinical Drug Information, LLC. September 2024.
  • Mohammed JU, Thomas D, Baker DE. Evaluation of the impact of a pharmacist-conducted hypertension clinic. J Pharm Bioallied Sci. 2024;16(2):79-85. DOI: 10.4103/jpbs.jpbs_1025_23
  • Staten AR, Baker DE. Cefepime/enmetazobactam. Hospital Pharmacy. 2024; ePub ahead of print. August 12, 2024. doi.org/10.1177/00185787241269112
  • Christopher L. Greer, Joshua J. Neumiller. Multidisciplinary diabetes management and education strategies in the inpatient rehabilitation setting. Diabetes Spectr. 2024;37(3):227-233.
  • Rodin NM, Miller JC, Ishibashi T, Powell A, McKeirnan KC. Focused Preceptor Feedback Assessing Student Pharmacists’ Ability to Administer Pediatric Immunizations. American Journal of Pharmaceutical Education. Published online, in press. doi:10.1016/j.ajpe.2024.101252

Presentations

  • Laffel L, Neumiller JJ. Transitions of Care. Presented at the 5th International Geriatric Diabetes Workshop of the International Geriatric Diabetes Society (IGDS). September 5, 2024. Boston, MA.
  • Mayhand KN, Alicic RZ, Reynolds CL, Kornowske LM, Jones CR, Petousis P, Shpaner L, Nicholas SB, Daratha KB, Thorpe RJ, Neumiller JJ, Norris KC, Tuttle KR. Predicting kidney function decline in African American populations with diabetes: a CURE-CKD registry analysis, 2013-2022. Presented at the 2024 AI for Health Equity Symposium AIM-AHEAD Annual Meeting. August 7, 2024. Atlanta, GA.
  • Zemke A, Alicic RZ, Reynolds CL, Kornowske LM, Jones CR, Petousis P, Shpaner L, Nicholas SB, Daratha KB, Bansal N, Neumiller JJ, Norris KC, Tuttle KR. Predicting kidney function decline in American Indian and Alaska Native populations with diabetes: cohort selection. Presented at the 2024 AI for Health Equity Symposium AIM-AHEAD Annual Meeting. August 7th, 2024. Atlanta, GA.
  • Duru OK, Vaduganathan M, Tuttle K, St. Peter W, Roberts G, Rangaswami J, Nicholas SB, Neumiller JJ, Mathew RO, Gee P, Alicic R. A systematic review of coordinated care in cardiovascular-kidney-metabolic (CKM) conditions. Poster PS3-140. Presented at the Society of General Internal Medicine 2024 Annual Meeting. May 15-18, 2024. Boston, MA.
Dilip Kumar Singh (second on left)
  • Dilip Kumar Singh (Prasad Lab) presented a poster titled “The Ontogeny and Interindividual Variability of Hydrolytic Drug-Metabolizing Enzymes in Human Liver” at the 2024 ISSX/JSSX meeting, held in Honolulu, Hawaii, USA. He presented novel work on ontogeny profiling and inter-individual variability of hydrolases, which is important for developing physiologically-based pharmacokinetic (PBPK) models to predict safer pediatric dosing. Dr. Singh was awarded first place in the Postdoctoral Scientists Poster Award category, highlighting the importance and impact of his research in the field of drug metabolism and disposition. The research is funded by The Proteomics-based Research Initiative for Non-Cytochrome P450 Enzymes (PRINCE) consortium, a research collaboration between Prasad lab, Washington State University and multiple pharmaceutical companies (AbbVie, Boehringer-Ingelheim, Genentech, Gilead, and Takeda). (September 15-18, 2024)
  • Dilip Kumar Singh (Prasad Lab) presented a poster titled “Deconvoluting the Global Metabolomic Changes Caused by a Complex Clinical Pharmacokinetic Cimetidine-Metformin Interaction Involving Organic Cation Transporters” at the American Society for Pharmacology and Experimental Therapeutics (ASPET) Meeting 2024, held in Arlington, VA. His work, which delves into the complex metabolomic changes triggered by this pharmacokinetic interaction, earned significant recognition. Singh was awarded second place in the Postdoctoral Scientists Poster Award category by the Division for Drug Metabolism and Disposition (DMDD), highlighting the importance and impact of his research in the field of pharmacology. His research focuses on the discovery of biomarkers for hepatic and renal drug transporters, aimed at ensuring the safe use of drugs by enabling the prediction of drug disposition, toxicity, efficacy, and interaction potential. (May 16-19, 2024)
Kari Gaither and Dilip Kumar Singh
  • Kari Gaither (Prasad Lab) presented a poster titled “Interplay of Alcohol Intake, Smoking, and Sex on the Protein Abundance of Hepatic Drug Metabolizing Enzymes and Transporters in Humans” at the American Society for Pharmacology and Experimental Therapeutics (ASPET) Meeting 2024, held in Arlington, VA. Gaither’s work received considerable acknowledgment and praise and was awarded third place in the Postdoctoral Scientists Poster Award category by the Division for Drug Metabolism and Disposition (DMDD) and Second Place in the Dolores C. Shockley Postdoctoral Poster Competition, highlighting the significance of her research in the field of pharmacology. (May 16-19, 2024)

Service

  • Kari Gaither was recently selected to represent WSU as a member of the new 2024-2025 cohort of ASPET Washington Fellows, where she will learn about science policy, the intersection of public policy, science, and the public, and how to become engaged in policy issues. As a part of the program, she will travel to Washington D.C. to speak to policy makers and legislators about her research and the critical need to increase science funding.

Grants & Awards

Student Achievement        

Pharmaceutical Sciences and Molecular Medicine students

Successfully Passed Final Defense:

  • Dr. Keti Bardhi, May 29, 2024
  • Dr. Shelby Metra, June 14, 2024
  • Dr. Paul Panipinto, September 24, 2024

Doctor of Pharmacy students

  • Ogburji L, Baker DE 2024. Drug Evaluation – Pivmecillinam (Pivya).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  September 2024.
  • Parsons A, Hitt E, Baker DE. Drug Evaluation – Tovorafenib (Ojemda).  In: Forrence E, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health.  September 2024.